IFP Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

IFP Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.6K	Buy	2,543 +2,297	+934%	+$15K	﹤0.01%	3130
2026 Q1	$1.7K	Sell	246 -45	-15%	-$347	﹤0.01%	4020
2025 Q4	$2.57K	Buy	291 +146	+101%	+$804	﹤0.01%	3739
2025 Q3	$724	Buy	+145	New	+$671	﹤0.01%	4057
2025 Q2	–	Sell	-10	Closed	-$44	–	4494
2025 Q1	$46	Hold	10	–	–	﹤0.01%	4038
2024 Q4	$48	Buy	+10	New	+$48	﹤0.01%	4274
2023 Q4	–	Sell	-295	Closed	-$1.27K	–	3356
2023 Q3	$1.27K	Hold	295	–	–	﹤0.01%	2944
2023 Q2	$1.94K	Hold	295	–	–	﹤0.01%	2887
2023 Q1	$5.22K	Hold	295	–	–	﹤0.01%	2547
2022 Q4	$5K	Hold	295	–	–	﹤0.01%	3823
2022 Q3	$5K	Hold	295	–	–	﹤0.01%	4066
2022 Q2	$5K	Hold	295	–	–	﹤0.01%	3833
2022 Q1	$5K	Hold	295	–	–	﹤0.01%	3833
2021 Q4	$5K	Hold	295	–	–	﹤0.01%	2518
2021 Q3	$5K	Hold	295	–	–	﹤0.01%	2579
2021 Q2	$6K	Hold	295	–	–	﹤0.01%	2426
2021 Q1	$4K	Hold	295	–	–	﹤0.01%	2504
2020 Q4	$4K	Buy	+295	New	+$3.55K	﹤0.01%	2438
2019 Q1	–	Sell	-1,425	Closed	-$37K	–	3434
2018 Q4	$37K	Buy	1,425 +225	+19%	+$5.29K	﹤0.01%	1786
2018 Q3	$28K	Buy	+1,200	New	+$24.5K	﹤0.01%	2263
2017 Q4	–	Sell	-1,000	Closed	-$18K	–	4111
2017 Q3	$18K	Buy	+1,000	New	+$16.7K	﹤0.01%	2678

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IFP Advisors's VNDA Position: Q2 2026 in Review

IFP Advisors increased its Vanda Pharmaceuticals (VNDA) stake by 934% in Q2 2026, buying an estimated $15K and bringing the position to 2,543 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3130.

IFP Advisors first reported a position in VNDA in Q3 2017 and has held it in 21 quarters since. The position peaked at $37K in Q4 2018. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

IFP Advisors held 2,543 shares of Vanda Pharmaceuticals worth $15.6K as of Q2 2026.
IFP Advisors bought 2,297 Vanda Pharmaceuticals shares in Q2 2026, an estimated $15K.
Vanda Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3130 holding.
IFP Advisors first reported a position in Vanda Pharmaceuticals in Q3 2017 and has held it in 21 quarters since.
IFP Advisors's Vanda Pharmaceuticals position peaked at $37K in Q4 2018.
172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.